{"id":1494,"date":"2026-09-09T08:22:27","date_gmt":"2026-09-09T08:22:27","guid":{"rendered":"https:\/\/nulifespanrx.com\/blog\/?p=1494"},"modified":"2026-09-10T18:48:49","modified_gmt":"2026-09-10T18:48:49","slug":"wegovy-vs-zepbound-cost","status":"publish","type":"post","link":"https:\/\/nulifespanrx.com\/blog\/wegovy-vs-zepbound-cost\/","title":{"rendered":"Wegovy vs. Zepbound Cost: Which GLP-1 Weight-Loss Drug Is More Affordable?"},"content":{"rendered":"

If you are choosing between Wegovy and Zepbound for weight management, cost is usually the deciding factor once your doctor has confirmed either one is appropriate for you. Before comparing manufacturer numbers, it is worth checking what pharmacies near you are actually charging<\/a>, since retail cash pricing on both drugs varies by location.<\/p>\n

Both are GLP-1 based injectable medications, but they are made by different companies, priced differently, and offer different self-pay and savings programs. Here is how the two actually compare on price in 2026, without insurance, with insurance, and through manufacturer discount programs.<\/p>\n

\"Price<\/a><\/p>\n

What Are Wegovy and Zepbound?<\/h2>\n

Wegovy (semaglutide) is made by Novo Nordisk and is FDA-approved for chronic weight management in adults and certain adolescents with obesity, as well as for reducing cardiovascular risk in adults with obesity or overweight and established heart disease. Zepbound (tirzepatide) is made by Eli Lilly and is FDA-approved for chronic weight management and for moderate to severe obstructive sleep apnea in adults with obesity.<\/p>\n

Both drugs work by mimicking gut hormones that regulate appetite and blood sugar, but Zepbound also acts on a second hormone receptor (GIP), which some clinical trials have linked to greater average weight loss. Your prescriber, not price alone, should guide which medication fits your health profile.<\/p>\n

Wegovy Cost Without Insurance<\/h2>\n

Wegovy\u2019s list price<\/a> (the manufacturer\u2019s official price before any discounts) is approximately $1,349 per month. At retail pharmacies without insurance or a discount program, cash prices commonly run between $1,200 and $1,800 per month depending on the pharmacy and location.<\/p>\n

Novo Nordisk also sells Wegovy directly to self-pay patients<\/a> through its NovoCare Pharmacy program:<\/p>\n\n\n\n\n\n\n\n\n
Wegovy Option<\/strong><\/td>\nEstimated Monthly Cost<\/strong><\/td>\n<\/tr>\n
Retail cash price (no insurance)<\/td>\n$1,200 to $1,800<\/td>\n<\/tr>\n
NovoCare Pharmacy, injection pen (standard doses)<\/td>\nAround $349, with a lower introductory rate for a patient\u2019s first two fills<\/td>\n<\/tr>\n
NovoCare Pharmacy, higher-dose (7.2 mg) pen<\/td>\nAround $399<\/td>\n<\/tr>\n
NovoCare Pharmacy, oral tablet<\/td>\nRoughly $149 to $299, depending on dose<\/td>\n<\/tr>\n
With commercial insurance plus the Wegovy Savings Card<\/td>\nAs low as $25, for eligible plans<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

These self-pay and savings figures come directly from Novo Nordisk\u2019s NovoCare program and can change, so it is worth confirming current pricing at novocare.com<\/a> before assuming a specific number applies to you.<\/p>\n

Zepbound Cost Without Insurance<\/h2>\n

\"Zepbound<\/p>\n

Zepbound\u2019s list price is roughly $1,086 per month regardless of dose. Retail cash prices without any discount typically fall between $1,000 and $1,500 per month.<\/p>\n

Eli Lilly\u2019s direct-to-patient program, LillyDirect, offers lower self-pay pricing for single-dose vials:<\/p>\n\n\n\n\n\n\n\n
Zepbound Option<\/strong><\/td>\nEstimated Monthly Cost<\/strong><\/td>\n<\/tr>\n
Retail cash price (no insurance)<\/td>\n$1,000 to $1,500<\/td>\n<\/tr>\n
LillyDirect self-pay vials, starter doses (2.5 mg, 5 mg)<\/td>\nAround $299<\/td>\n<\/tr>\n
LillyDirect self-pay vials, higher doses (7.5 mg to 15 mg)<\/td>\nAround $449<\/td>\n<\/tr>\n
With commercial insurance plus the Zepbound Savings Card<\/td>\nAs low as $25, for eligible plans<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

As with Wegovy, these LillyDirect prices and eligibility rules are set by the manufacturer and can be updated, so confirm current terms at lillydirect.lilly.com<\/a> before relying on a specific figure.<\/p>\n

Wegovy vs. Zepbound: Side-by-Side Cost Comparison<\/h2>\n\n\n\n\n\n\n\n\n\n
Factor<\/strong><\/td>\nWegovy<\/strong><\/td>\nZepbound<\/strong><\/td>\n<\/tr>\n
Manufacturer<\/td>\nNovo Nordisk<\/td>\nEli Lilly<\/td>\n<\/tr>\n
List price (retail, before discounts)<\/td>\nAbout $1,349\/month<\/td>\nAbout $1,086\/month<\/td>\n<\/tr>\n
Manufacturer self-pay program<\/td>\nNovoCare Pharmacy, roughly $149 to $399\/month<\/td>\nLillyDirect, roughly $299 to $449\/month<\/td>\n<\/tr>\n
Savings card with commercial insurance<\/td>\nAs low as $25\/month<\/td>\nAs low as $25\/month<\/td>\n<\/tr>\n
Available as an oral tablet<\/td>\nYes<\/td>\nNot currently<\/td>\n<\/tr>\n
Federal government plans (Medicare, Medicaid, TRICARE, VA)<\/td>\nSavings cards excluded by law<\/td>\nSavings cards excluded by law<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

On list price alone, Zepbound is generally the lower-priced brand. On manufacturer self-pay pricing, Wegovy\u2019s oral tablet option can undercut Zepbound\u2019s cheapest vial tier for patients who are candidates for the pill form. For patients whose commercial insurance actually covers the drug, both companies\u2019 savings cards can bring the cost down to a similar range.<\/p>\n

Why the Price You Pay May Differ From These Numbers<\/h2>\n

\"Price<\/p>\n

Several factors change what you personally will be charged:<\/p>\n